Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsCollin, Simon M
Lewis, Sarah J
Lane, J Athene
Smith, George Davey
Neal, David E
Hamdy, Freddie C
Benediktsdottir, Kristrun R
Eeles, Rosalind A
Al Olama, Ali Amin
Easton, Douglas F
Martin, Richard M
MetadataShow full item record
CitationCancer Epidemiol. Biomarkers Prev. 2009, 18(9):2528-39
AbstractFolate-pathway gene polymorphisms have been implicated in several cancers and investigated inconclusively in relation to prostate cancer. We conducted a systematic review, which identified nine case-control studies (eight included, one excluded). We also included data from four genome-wide association studies and from a case-control study nested within the UK population-based Prostate Testing for Cancer and Treatment study. We investigated by meta-analysis the effects of eight polymorphisms: MTHFR C677T (rs1801133; 12 studies; 10,745 cases; 40,158 controls), MTHFR A1298C (rs1801131; 5 studies; 3,176 cases; 4,829 controls), MTR A2756G (rs1805087; 8 studies; 7,810 cases; 37,543 controls), MTRR A66G (rs1801394; 4 studies; 3,032 cases; 4,515 controls), MTHFD1 G1958A (rs2236225; 6 studies; 7,493 cases; 36,941 controls), SLC19A1/RFC1 G80A (rs1051266; 4 studies; 6,222 cases; 35,821 controls), SHMT1 C1420T (rs1979277; 2 studies; 2,689 cases; 4,110 controls), and FOLH1 T1561C (rs202676; 5 studies; 6,314 cases; 35,190 controls). The majority (10 of 13) of eligible studies had 100% Caucasian subjects; only one study had <90% Caucasian subjects. We found weak evidence of dominant effects of two alleles: MTR 2756A>G [random effects pooled odds ratio, 1.06 (1.00-1.12); P = 0.06 (P = 0.59 for heterogeneity across studies)] and SHMT1 1420C>T [random effects pooled odds ratio, 1.11 (1.00-1.22); P = 0.05 (P = 0.38 for heterogeneity across studies)]. We found no effect of MTHFR 677C>T or any of the other alleles in dominant, recessive or additive models, or in comparing a/a versus A/A homozygous. Neither did we find any difference in effects on advanced or localized cancers. Our meta-analysis suggests that known common folate-pathway single nucleotide polymorphisms do not have significant effects on susceptibility to prostate cancer.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Possible selection of host folate pathway gene polymorphisms in patients with malaria from a malaria endemic region in North East India.
- Authors: Mirgal D, Ghosh K, Mahanta J, Dutta P, Shetty S
- Issue date: 2016 May
- Association between SNPs in genes involved in folate metabolism and preterm birth risk.
- Authors: Wang BJ, Liu MJ, Wang Y, Dai JR, Tao JY, Wang SN, Zhong N, Chen Y
- Issue date: 2015 Feb 2
- Genetic polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) genes associated with pathological characteristics of prostate cancer in the Ecuadorian population.
- Authors: López-Cortés A, Jaramillo-Koupermann G, Muñoz MJ, Cabrera A, Echeverría C, Rosales F, Vivar N, Paz-y-Miño C
- Issue date: 2013 Dec
- Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia.
- Authors: Roffman JL, Brohawn DG, Nitenson AZ, Macklin EA, Smoller JW, Goff DC
- Issue date: 2013 Mar
- [Polymorphic variants of folate metabolizing genes (C677T and A1298C MTHFR, C1420T SHMT1 and G1958A MTHFD) are not associated with the risk of breast cancer in West Siberian Region of Russia].
- Authors: Vaĭner AS, Boiarskikh UA, Voronina EN, Selezneva IA, Sinkina TV, Lazarev AF, Petrova VD, Filipenko ML
- Issue date: 2010 Sep-Oct